Ligand · A1IQO
A1IQO · (1~{R},3~{S},5~{Z})-5-[(2~{E})-2-[(1~{S},3~{a}~{S},7~{a}~{S})-7~{a}-methyl-1-(4-trimethylsilylbuta-1,3-diynyl)-2,3,3~{a},5,6,7-hexahydro-1~{H}-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol
A1IQO, (1~{R},3~{S},5~{Z})-5-[(2~{E})-2-[(1~{S},3~{a}~{S},7~{a}~{S})-7~{a}-methyl-1-(4-trimethylsilylbuta-1,3-diynyl)-2,3,3~{a},5,6,7-hexahydro-1~{H}-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol (C26 H36 O2 Si, 408.6…
- Component
- A1IQO
- Formula
- C26 H36 O2 Si
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
A1IQO in 1 structure; the first of them:
- 9GYK · Vitamin D receptor in complex with Sila-f · A1IQO A502 · binds TYR175, TYR179, PHE182, LEU255, LEU258, ALA259, LEU261, VAL262 and 18 more
Residues it binds most
LEU 1, TYR 1, SER 1, ALA 1, HIS 1, PHE 1, VAL 1, ARG 1, CYS 1, ILE 1 (residue and the binding sites it lines).
Found with
- ACT · Acetate ion
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.